Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 11:44 PM
Study NCT ID:
NCT04754594
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2021-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Sponsor:
BioNTech SE
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-09
First Submit QC Date:
None
Study First Post Date:
2021-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-14
Results First Submit QC Date:
None
Results First Post Date:
2024-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-12-06
Last Update Post Date Type:
ACTUAL